Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.350
+0.051 (2.22%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Synaptogenix Statistics

Total Valuation

Synaptogenix has a market cap or net worth of $3.39 million. The enterprise value is -$14.27 million.

Market Cap 3.39M
Enterprise Value -14.27M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Synaptogenix has 1.39 million shares outstanding. The number of shares has increased by 164.69% in one year.

Current Share Class 1.39M
Shares Outstanding 1.39M
Shares Change (YoY) +164.69%
Shares Change (QoQ) +2.83%
Owned by Insiders (%) 0.66%
Owned by Institutions (%) 4.14%
Float 1.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.56
P/TBV Ratio 0.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.47

Current Ratio 17.47
Quick Ratio 17.41
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -78.91% and return on invested capital (ROIC) is -26.31%.

Return on Equity (ROE) -78.91%
Return on Assets (ROA) -17.43%
Return on Invested Capital (ROIC) -26.31%
Return on Capital Employed (ROCE) -40.74%
Revenue Per Employee n/a
Profits Per Employee -$3.39M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.12% in the last 52 weeks. The beta is 1.30, so Synaptogenix's price volatility has been higher than the market average.

Beta (5Y) 1.30
52-Week Price Change -48.12%
50-Day Moving Average 2.54
200-Day Moving Average 3.11
Relative Strength Index (RSI) 54.27
Average Volume (20 Days) 10,675

Short Selling Information

The latest short interest is 1,433, so 0.10% of the outstanding shares have been sold short.

Short Interest 1,433
Short Previous Month 11,978
Short % of Shares Out 0.10%
Short % of Float 0.10%
Short Ratio (days to cover) 0.11

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -6.81M
Pretax Income -4.53M
Net Income -13.56M
EBITDA -6.81M
EBIT -6.81M
Earnings Per Share (EPS) -$10.99
Full Income Statement

Balance Sheet

The company has $17.66 million in cash and n/a in debt, giving a net cash position of $17.66 million or $12.70 per share.

Cash & Cash Equivalents 17.66M
Total Debt n/a
Net Cash 17.66M
Net Cash Per Share $12.70
Equity (Book Value) 6.78M
Book Value Per Share 4.32
Working Capital 16.71M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.88M
Capital Expenditures n/a
Free Cash Flow -4.88M
FCF Per Share -$3.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -164.69%
Shareholder Yield n/a
Earnings Yield -399.84%
FCF Yield -144.03%

Analyst Forecast

The average price target for Synaptogenix is $14.00, which is 495.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.00
Price Target Difference 495.75%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date Apr 5, 2024
Split Type Reverse
Split Ratio 0.04:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2